Literature DB >> 16448222

Protease activity in protein-free NS0 myeloma cell cultures.

Erika Spens1, Lena Häggström.   

Abstract

Zymography of concentrated conditioned medium (CM) from protein-free NS0 myeloma cell cultures showed that this cell line produced and released/secreted several proteases. Two caseinolytic activities at 45-50 and 90 kDa were identified as aspartic acid proteases, and at least two cathepsins of the papain-like cysteine protease family with molecular masses of 30-35 kDa were found by gelatin zymography. One of these cathepsins was identified as cathepsin L by using an enzyme assay exploiting the substrate Z-Phe-Arg-AMC and the inhibitor Z-Phe-Tyr-t(Bu)-DMK. The aspartic acid and cysteine proteases were active only at acidic pH and are therefore not a potential risk for degrading the product or affecting cell growth during culture. Secreted proforms of cathepsins may, however, possess mitogenic functions, but addition of anti-procathepsin L antibodies to NS0 cultures did not influence proliferation. The recombinant antibody product was not degraded in cell-free CM incubated at pH 7, but when the pH was decreased to 3.5-4, the aspartic acid proteases degraded the product. Gelatin zymography also revealed the presence of several serine proteases in NS0 CM, one at 85 kDa and two at 50 kDa, with pH optima close to culture pH. Addition of the serine protease inhibitor aprotinin significantly increased the specific proliferation rate as compared to the control. In addition to these data, N-terminal amino acid sequencing identified two proteins in NS0 CM as the protease inhibitors secretory leukocyte protease inhibitor and cystatin C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16448222     DOI: 10.1007/s11626-005-0004-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  31 in total

1.  Monitoring of the production of monoclonal antibodies by hybridomas. Part II: Characterization and purification of acid proteases present in cell culture supernatant.

Authors:  R van Erp; M Adorf; A P van Sommeren; T C Gribnau
Journal:  J Biotechnol       Date:  1991-10       Impact factor: 3.307

2.  Epidermal growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor.

Authors:  L T Hunt; W C Barker; M O Dayhoff
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

Review 3.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.

Authors:  H Fritz; G Wunderer
Journal:  Arzneimittelforschung       Date:  1983

Review 4.  Evolution of proteolytic enzymes.

Authors:  H Neurath
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

5.  Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes.

Authors:  T Nakamura; O Asami; K Tanaka; A Ichihara
Journal:  Exp Cell Res       Date:  1984-11       Impact factor: 3.905

Review 6.  Matrix metalloproteinases in multiple myeloma.

Authors:  T Kelly; M Børset; E Abe; D Gaddy-Kurten; R D Sanderson
Journal:  Leuk Lymphoma       Date:  2000-04

7.  Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.

Authors:  H Kirschke; R Eerola; V K Hopsu-Havu; D Brömme; E Vuorio
Journal:  Eur J Cancer       Date:  2000-04       Impact factor: 9.162

8.  Molecular cloning, sequence analysis and expression distribution of rainbow trout (Oncorhynchus mykiss) cystatin C.

Authors:  F Li; H An; T A Seymour; C S Bradford; M T Morrissey; G S Bailey; A Helmrich; D W Barnes
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-10       Impact factor: 2.231

9.  Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator.

Authors:  Esther P M Tjin; Patrick W B Derksen; Hiroaki Kataoka; Marcel Spaargaren; Steven T Pals
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

10.  Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.

Authors:  P G Hargreaves; F Wang; J Antcliff; G Murphy; J Lawry; R G Russell; P I Croucher
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

View more
  1 in total

1.  Suppression of IgM Proteolysis by Conformational Stabilization Through Excipients.

Authors:  Monika Mueller; Maybelle Q T Loh; Pete Gagnon
Journal:  Sci Pharm       Date:  2015-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.